nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiotropium—Pain in extremity—Metformin—polycystic ovary syndrome	0.00492	0.0477	CcSEcCtD
Tiotropium—CYP3A4—urine—polycystic ovary syndrome	0.00481	0.113	CbGeAlD
Tiotropium—CYP2D6—urine—polycystic ovary syndrome	0.00474	0.111	CbGeAlD
Tiotropium—Dehydration—Metformin—polycystic ovary syndrome	0.00457	0.0444	CcSEcCtD
Tiotropium—Angina pectoris—Metformin—polycystic ovary syndrome	0.00414	0.0402	CcSEcCtD
Tiotropium—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00395	0.0383	CcSEcCtD
Tiotropium—Rhinitis—Metformin—polycystic ovary syndrome	0.00341	0.0331	CcSEcCtD
Tiotropium—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00335	0.0325	CcSEcCtD
Tiotropium—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00334	0.0324	CcSEcCtD
Tiotropium—Eye disorder—Metformin—polycystic ovary syndrome	0.00318	0.0309	CcSEcCtD
Tiotropium—Angiopathy—Metformin—polycystic ovary syndrome	0.00309	0.03	CcSEcCtD
Tiotropium—Immune system disorder—Metformin—polycystic ovary syndrome	0.00307	0.0298	CcSEcCtD
Tiotropium—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00307	0.0298	CcSEcCtD
Tiotropium—Malnutrition—Metformin—polycystic ovary syndrome	0.00296	0.0287	CcSEcCtD
Tiotropium—Vision blurred—Metformin—polycystic ovary syndrome	0.00279	0.0271	CcSEcCtD
Tiotropium—Syncope—Metformin—polycystic ovary syndrome	0.00266	0.0258	CcSEcCtD
Tiotropium—SLC22A4—endometrium—polycystic ovary syndrome	0.00262	0.0617	CbGeAlD
Tiotropium—Palpitations—Metformin—polycystic ovary syndrome	0.00262	0.0254	CcSEcCtD
Tiotropium—Loss of consciousness—Metformin—polycystic ovary syndrome	0.0026	0.0253	CcSEcCtD
Tiotropium—Hypertension—Metformin—polycystic ovary syndrome	0.00256	0.0248	CcSEcCtD
Tiotropium—Chest pain—Metformin—polycystic ovary syndrome	0.00252	0.0245	CcSEcCtD
Tiotropium—Myalgia—Metformin—polycystic ovary syndrome	0.00252	0.0245	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.0025	0.0243	CcSEcCtD
Tiotropium—Oedema—Metformin—polycystic ovary syndrome	0.00242	0.0235	CcSEcCtD
Tiotropium—Infection—Metformin—polycystic ovary syndrome	0.0024	0.0233	CcSEcCtD
Tiotropium—Shock—Metformin—polycystic ovary syndrome	0.00238	0.0231	CcSEcCtD
Tiotropium—SLC22A4—pituitary gland—polycystic ovary syndrome	0.00237	0.0558	CbGeAlD
Tiotropium—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00237	0.023	CcSEcCtD
Tiotropium—SLC22A4—adipose tissue—polycystic ovary syndrome	0.00236	0.0556	CbGeAlD
Tiotropium—Skin disorder—Metformin—polycystic ovary syndrome	0.00235	0.0228	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.0022	0.0214	CcSEcCtD
Tiotropium—Paraesthesia—Metformin—polycystic ovary syndrome	0.00217	0.0211	CcSEcCtD
Tiotropium—Dyspepsia—Metformin—polycystic ovary syndrome	0.00213	0.0206	CcSEcCtD
Tiotropium—SLC22A4—adrenal gland—polycystic ovary syndrome	0.00212	0.0499	CbGeAlD
Tiotropium—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00209	0.0202	CcSEcCtD
Tiotropium—Constipation—Metformin—polycystic ovary syndrome	0.00207	0.0201	CcSEcCtD
Tiotropium—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00198	0.0192	CcSEcCtD
Tiotropium—SLC22A4—vagina—polycystic ovary syndrome	0.00197	0.0462	CbGeAlD
Tiotropium—SLC22A5—adrenal cortex—polycystic ovary syndrome	0.00194	0.0457	CbGeAlD
Tiotropium—Urticaria—Metformin—polycystic ovary syndrome	0.00192	0.0186	CcSEcCtD
Tiotropium—Abdominal pain—Metformin—polycystic ovary syndrome	0.00191	0.0185	CcSEcCtD
Tiotropium—CHRM3—adipose tissue—polycystic ovary syndrome	0.00187	0.0439	CbGeAlD
Tiotropium—CHRM2—endocrine gland—polycystic ovary syndrome	0.00178	0.0419	CbGeAlD
Tiotropium—SLC22A5—endometrium—polycystic ovary syndrome	0.00174	0.0408	CbGeAlD
Tiotropium—Pruritus—Metformin—polycystic ovary syndrome	0.00171	0.0166	CcSEcCtD
Tiotropium—CHRM1—endocrine gland—polycystic ovary syndrome	0.00162	0.0382	CbGeAlD
Tiotropium—Dizziness—Metformin—polycystic ovary syndrome	0.0016	0.0155	CcSEcCtD
Tiotropium—SLC22A5—pituitary gland—polycystic ovary syndrome	0.00157	0.0369	CbGeAlD
Tiotropium—SLC22A5—adipose tissue—polycystic ovary syndrome	0.00156	0.0368	CbGeAlD
Tiotropium—CHRM3—female gonad—polycystic ovary syndrome	0.00156	0.0367	CbGeAlD
Tiotropium—Vomiting—Metformin—polycystic ovary syndrome	0.00154	0.0149	CcSEcCtD
Tiotropium—Rash—Metformin—polycystic ovary syndrome	0.00152	0.0148	CcSEcCtD
Tiotropium—Dermatitis—Metformin—polycystic ovary syndrome	0.00152	0.0148	CcSEcCtD
Tiotropium—Headache—Metformin—polycystic ovary syndrome	0.00151	0.0147	CcSEcCtD
Tiotropium—CHRM3—endocrine gland—polycystic ovary syndrome	0.00145	0.0341	CbGeAlD
Tiotropium—Nausea—Metformin—polycystic ovary syndrome	0.00144	0.0139	CcSEcCtD
Tiotropium—SLC22A5—adrenal gland—polycystic ovary syndrome	0.0014	0.033	CbGeAlD
Tiotropium—SLC22A5—female gonad—polycystic ovary syndrome	0.00131	0.0308	CbGeAlD
Tiotropium—SLC22A5—vagina—polycystic ovary syndrome	0.0013	0.0306	CbGeAlD
Tiotropium—CYP2D6—female gonad—polycystic ovary syndrome	0.000844	0.0199	CbGeAlD
Tiotropium—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000798	0.0188	CbGeAlD
Tiotropium—CYP2D6—endocrine gland—polycystic ovary syndrome	0.000785	0.0185	CbGeAlD
Tiotropium—CHRM3—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000239	0.00028	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000238	0.000278	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000237	0.000278	CbGpPWpGaD
Tiotropium—CHRM2—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000236	0.000277	CbGpPWpGaD
Tiotropium—CHRM2—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000236	0.000276	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000235	0.000275	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000233	0.000273	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—INSR—polycystic ovary syndrome	0.000232	0.000271	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.00023	0.000269	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000229	0.000268	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000227	0.000266	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000224	0.000262	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000223	0.000261	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—SULT2A1—polycystic ovary syndrome	0.000221	0.000259	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000221	0.000259	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.00022	0.000258	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—FST—polycystic ovary syndrome	0.000218	0.000255	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—FST—polycystic ovary syndrome	0.000217	0.000254	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000217	0.000254	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000217	0.000254	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	0.000216	0.000253	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000216	0.000253	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000215	0.000252	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—FST—polycystic ovary syndrome	0.000215	0.000252	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000215	0.000251	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—PGR—polycystic ovary syndrome	0.000215	0.000251	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—RRM2—polycystic ovary syndrome	0.000214	0.000251	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000214	0.000251	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000214	0.00025	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000214	0.00025	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000213	0.000249	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000213	0.000249	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—LHB—polycystic ovary syndrome	0.000212	0.000248	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—LHB—polycystic ovary syndrome	0.00021	0.000246	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000208	0.000244	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000207	0.000243	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—YAP1—polycystic ovary syndrome	0.000206	0.000242	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000205	0.00024	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	0.000205	0.00024	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000201	0.000236	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000201	0.000235	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000201	0.000235	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.0002	0.000235	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—GHRL—polycystic ovary syndrome	0.0002	0.000234	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—PLAT—polycystic ovary syndrome	0.0002	0.000234	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000199	0.000233	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000199	0.000233	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—SCT—polycystic ovary syndrome	0.000199	0.000233	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000199	0.000232	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000198	0.000232	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—NAMPT—polycystic ovary syndrome	0.000198	0.000232	CbGpPWpGaD
Tiotropium—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000198	0.000232	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000197	0.00023	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—SCT—polycystic ovary syndrome	0.000197	0.00023	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000196	0.00023	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—CYP11A1—polycystic ovary syndrome	0.000196	0.000229	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	0.000196	0.000229	CbGpPWpGaD
Tiotropium—CHRM1—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000195	0.000228	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000194	0.000228	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000192	0.000225	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—ATF1—polycystic ovary syndrome	0.00019	0.000223	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.00019	0.000223	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.00019	0.000222	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000188	0.00022	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000187	0.000219	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000186	0.000218	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000186	0.000217	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000185	0.000217	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—AKR1C3—polycystic ovary syndrome	0.000185	0.000216	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000185	0.000216	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000185	0.000216	CbGpPWpGaD
Tiotropium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000185	0.000216	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000185	0.000216	CbGpPWpGaD
Tiotropium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000184	0.000215	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000183	0.000214	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000183	0.000214	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—CYP17A1—polycystic ovary syndrome	0.000182	0.000213	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000182	0.000213	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.00018	0.000211	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000176	0.000206	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000175	0.000204	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	0.000174	0.000204	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—PRL—polycystic ovary syndrome	0.000174	0.000204	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000173	0.000203	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000173	0.000202	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000171	0.0002	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000171	0.0002	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—GAB1—polycystic ovary syndrome	0.00017	0.000199	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000169	0.000198	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000169	0.000198	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000169	0.000197	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000168	0.000196	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	0.000166	0.000195	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000165	0.000193	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000163	0.000191	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—INSR—polycystic ovary syndrome	0.000163	0.00019	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—INSR—polycystic ovary syndrome	0.000161	0.000189	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—TH—polycystic ovary syndrome	0.000158	0.000184	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000155	0.000182	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000155	0.000181	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—SLC2A4—polycystic ovary syndrome	0.000153	0.000179	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000153	0.000179	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000153	0.000179	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000153	0.000179	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000152	0.000178	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	0.000152	0.000178	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000151	0.000177	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000151	0.000176	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PGR—polycystic ovary syndrome	0.000151	0.000176	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PGR—polycystic ovary syndrome	0.000149	0.000175	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	0.000148	0.000174	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000146	0.000171	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—CYP19A1—polycystic ovary syndrome	0.000144	0.000169	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	0.000144	0.000168	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000143	0.000168	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000141	0.000166	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000141	0.000164	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000141	0.000164	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PLAT—polycystic ovary syndrome	0.00014	0.000164	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—GHRL—polycystic ovary syndrome	0.00014	0.000164	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000139	0.000162	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000139	0.000162	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000135	0.000158	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000135	0.000158	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.000134	0.000157	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000134	0.000157	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000134	0.000156	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000134	0.000156	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000132	0.000155	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	0.000132	0.000155	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000131	0.000153	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.00013	0.000153	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.00013	0.000152	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.00013	0.000152	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000129	0.000151	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—GNAS—polycystic ovary syndrome	0.000129	0.000151	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000128	0.00015	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	0.000128	0.00015	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	0.000128	0.00015	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000124	0.000145	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	0.000123	0.000144	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000123	0.000144	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000123	0.000144	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000123	0.000144	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000123	0.000144	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000123	0.000143	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—NCOR1—polycystic ovary syndrome	0.000122	0.000143	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PRL—polycystic ovary syndrome	0.000122	0.000143	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000122	0.000143	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000121	0.000142	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PRL—polycystic ovary syndrome	0.000121	0.000142	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—LEP—polycystic ovary syndrome	0.00012	0.000141	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	0.000119	0.000139	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000118	0.000138	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000118	0.000138	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	0.000117	0.000137	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000117	0.000137	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000116	0.000136	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—CYP1A1—polycystic ovary syndrome	0.000116	0.000136	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000116	0.000136	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000115	0.000134	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	0.000114	0.000133	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	0.000111	0.000129	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	0.000109	0.000127	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	0.000109	0.000127	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—MTHFR—polycystic ovary syndrome	0.000108	0.000127	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000108	0.000126	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000108	0.000126	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000107	0.000125	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000106	0.000125	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—POMC—polycystic ovary syndrome	0.000103	0.000121	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000103	0.00012	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—INS—polycystic ovary syndrome	0.000103	0.00012	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000102	0.00012	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000101	0.000119	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000101	0.000118	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000101	0.000118	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—NRG1—polycystic ovary syndrome	9.96e-05	0.000117	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—IGF1—polycystic ovary syndrome	9.92e-05	0.000116	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	9.92e-05	0.000116	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—AKT2—polycystic ovary syndrome	9.91e-05	0.000116	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	9.7e-05	0.000113	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.42e-05	0.00011	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—TH—polycystic ovary syndrome	9.42e-05	0.00011	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	9.39e-05	0.00011	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	9.16e-05	0.000107	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PPARG—polycystic ovary syndrome	8.78e-05	0.000103	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—POMC—polycystic ovary syndrome	8.66e-05	0.000101	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	8.64e-05	0.000101	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	8.64e-05	0.000101	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	8.61e-05	0.000101	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—IRS2—polycystic ovary syndrome	8.61e-05	0.000101	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—INS—polycystic ovary syndrome	8.61e-05	0.000101	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—IRS2—polycystic ovary syndrome	8.53e-05	9.98e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—LEP—polycystic ovary syndrome	8.45e-05	9.9e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—LEP—polycystic ovary syndrome	8.43e-05	9.86e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	8.37e-05	9.8e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—LEP—polycystic ovary syndrome	8.35e-05	9.77e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	8.07e-05	9.44e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	7.75e-05	9.07e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	7.69e-05	9e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	7.65e-05	8.96e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—IL6—polycystic ovary syndrome	7.59e-05	8.88e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	7.54e-05	8.83e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—IRS1—polycystic ovary syndrome	7.52e-05	8.8e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—IRS1—polycystic ovary syndrome	7.45e-05	8.71e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	7.32e-05	8.57e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—POMC—polycystic ovary syndrome	7.26e-05	8.5e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—POMC—polycystic ovary syndrome	7.24e-05	8.47e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	7.23e-05	8.46e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—INS—polycystic ovary syndrome	7.22e-05	8.45e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—INS—polycystic ovary syndrome	7.2e-05	8.43e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—POMC—polycystic ovary syndrome	7.17e-05	8.39e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—INS—polycystic ovary syndrome	7.13e-05	8.34e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	7.12e-05	8.33e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	6.99e-05	8.18e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	6.98e-05	8.17e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—IGF1—polycystic ovary syndrome	6.96e-05	8.15e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—AKT2—polycystic ovary syndrome	6.96e-05	8.14e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	6.94e-05	8.13e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—IGF1—polycystic ovary syndrome	6.9e-05	8.07e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—AKT2—polycystic ovary syndrome	6.89e-05	8.07e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.63e-05	7.76e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.61e-05	7.74e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.55e-05	7.66e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.48e-05	7.59e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	6.47e-05	7.58e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—TH—polycystic ovary syndrome	6.16e-05	7.21e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	5.99e-05	7.01e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	5.63e-05	6.59e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	5.34e-05	6.25e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—IL6—polycystic ovary syndrome	5.33e-05	6.23e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—IL6—polycystic ovary syndrome	5.27e-05	6.17e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	5.25e-05	6.14e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	5.18e-05	6.06e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—INS—polycystic ovary syndrome	5.15e-05	6.03e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	5.03e-05	5.88e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	4.79e-05	5.6e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.56e-05	5.34e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.55e-05	5.32e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	4.54e-05	5.31e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.5e-05	5.27e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—IL6—polycystic ovary syndrome	4.48e-05	5.25e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	4.23e-05	4.95e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	3.43e-05	4.02e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	3.38e-05	3.96e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—INS—polycystic ovary syndrome	3.37e-05	3.94e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—IL6—polycystic ovary syndrome	3.16e-05	3.69e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—IL6—polycystic ovary syndrome	3.15e-05	3.68e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—IL6—polycystic ovary syndrome	3.12e-05	3.65e-05	CbGpPWpGaD
